UK markets open in 2 hours 37 minutes

Taysha Gene Therapies, Inc. (TSHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3500-0.1800 (-7.11%)
At close: 04:00PM EDT
2.4600 +0.11 (+4.68%)
After hours: 06:15PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 439.49M
Enterprise value 356.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.66
Price/book (mrq)5.86
Enterprise value/revenue 23.08
Enterprise value/EBITDA -3.39

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3251.80%
S&P500 52-week change 322.64%
52-week high 33.8900
52-week low 30.5000
50-day moving average 32.5775
200-day moving average 32.0770

Share statistics

Avg vol (3-month) 32.79M
Avg vol (10-day) 31.73M
Shares outstanding 5187.02M
Implied shares outstanding 6187.02M
Float 8100.11M
% held by insiders 124.77%
% held by institutions 169.84%
Shares short (28 Mar 2024) 416.99M
Short ratio (28 Mar 2024) 43.89
Short % of float (28 Mar 2024) 412.80%
Short % of shares outstanding (28 Mar 2024) 49.08%
Shares short (prior month 29 Feb 2024) 413.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-438.32%

Management effectiveness

Return on assets (ttm)-29.84%
Return on equity (ttm)-294.04%

Income statement

Revenue (ttm)15.45M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)44.00%
Gross profit (ttm)N/A
EBITDA -70M
Net income avi to common (ttm)-111.57M
Diluted EPS (ttm)-0.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)143.94M
Total cash per share (mrq)0.77
Total debt (mrq)61.88M
Total debt/equity (mrq)82.58%
Current ratio (mrq)4.08
Book value per share (mrq)0.40

Cash flow statement

Operating cash flow (ttm)-73.02M
Levered free cash flow (ttm)-68.51M